Answers are grounded in this paper and cite their sources.
Objectives Studies have found that moral injury (MI) can be easily missed in clinical assessments and most measures of MI have been developed for and with US military samples. As MI is increasingly recognised in non-military samples, existing scales may not be appropriate to civilian experiences. Design To design and validate the Moral Injury Scale (MORIS), a self-report measure of exposure to potentially morally injurious events (PMIEs), moral injury-related distress, and associated risk and protective factors, in UK samples pre-screened for reporting morally or psychologically distressing experiences. Setting UK general population. Participants We administered an initial set of 47 items to 592 participants and conducted exploratory factor analysis. The reduced MORIS was administered to an independent sample of 382 participants and confirmatory factor analysis was conducted. Primary outcome measures The validity and performance characteristics of the MORIS were assessed against validated measures of mental ill health. Receiver operating characteristic (ROC) curves were used to calculate a likely cut off score for detecting conditions that are associated with moral injury. Results Analysis yielded factors for assessing exposure to PMIEs; time since event; MI-related distress; and risk and protective factors. Good convergent validity was evidenced against the measure of MI and mental health symptoms. Confirmatory factor analysis demonstrated a good fit for the model. ROC analyses suggested that a score of ≥18 (ROC 0.83; 95% CI 0.77 - 0.90) on the MORIS Distress subscale may indicate elevated levels of moral injury-related distress within this sample; however, this finding should be considered exploratory at this stage. Conclusions This study provides preliminary evidence supporting the reliability, unidimensional factor structure, and convergent validity of the MORIS Distress subscale among UK adults reporting morally or psychologically distressing experiences. Data set information Please see data availability statement. Trial registration number N/A
No takes yet. Share an insight, caveat, or question.
Williamson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: